Ceapro Inc. (OTCMKTS:CRPOF – Get Free Report) traded down 13% on Monday . The stock traded as low as $0.17 and last traded at $0.17. 6,000 shares changed hands during mid-day trading, a decline of 61% from the average session volume of 15,466 shares. The stock had previously closed at $0.20.
Ceapro Stock Performance
The firm has a market capitalization of $13.31 million, a price-to-earnings ratio of -2.83 and a beta of 1.47. The firm has a 50 day moving average price of $0.17 and a two-hundred day moving average price of $0.17.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Recommended Stories
- Five stocks we like better than Ceapro
- How to Find Undervalued Stocks
- Intel: Is Now the Time to Be Brave?Â
- Investing in Construction Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- CD Calculator: Certificate of Deposit Calculator
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
